Physical activity and survival after breast cancer diagnosis: meta-analysis of published studiesEzzeldin M Ibrahim
Oncology Center, International Medical Center, PO Box 2172, Jeddah, 21451, Kingdom of Saudi Arabia
Med Oncol 28:753-65. 2011
..The current meta-analysis provides evidence for an inverse relationship between PA and mortality in patients with breast cancer and supports the notion that appropriate PA should be embraced by breast cancer survivors...
- Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis
Ezzeldin M Ibrahim
Oncology Center of Excellence, International Medical Center, P O Box 2172, Jeddah, 21451, Kingdom of Saudi Arabia
Lung 191:117-34. 2013
..The aim of this meta-analysis was to quantify such risk and to analyze contributing risk factors in HL survivors...
Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysisEzzeldin M Ibrahim
Oncology Center of Excellence, International Medical Center, PO Box 2172, Jeddah 21451, Saudi Arabia
BMC Cancer 12:197. 2012
..We planned this meta-analysis to quantify the long-term risk of SBC and analyze the contributing risk factors among HL survivors...
- Cetuximab-based therapy is effective in chemotherapy-naïve patients with advanced and metastatic non-small-cell lung cancer: a meta-analysis of randomized controlled trials
Ezzeldin M Ibrahim
Oncology Center of Excellence, International Medical Center, Kingdom of Saudi Arabia
Lung 189:193-8. 2011
..CBT produced significant clinical benefit with acceptable toxicity as a first-line strategy in patients with advanced/metastatic NSCLC. Further research is needed to identify markers predictive of cetuximab benefit in that disease...
- Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials
Ezzeldin M Ibrahim
Oncology Center of Excellence, International Medical Center, PO Box 2172, Jeddah 21451, Kingdom of Saudi Arabia
Med Oncol 28:S310-7. 2011
..The benefit was demonstrated in most subgroup analyses. Further research to better define potential responders is needed...
Safety and efficacy of cetuximab-chemotherapy combination in Saudi patients with metastatic colorectal cancerEzzeldin M Ibrahim
Department of Oncology and Hematology, Sections of Medical Oncology, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia
Indian J Cancer 44:56-61. 2007
..This prospective phase-II study was designed to assess the efficacy and safety of CBCC as first-, second- or third-line among Saudi patients with mCRC...
- Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia
Ezzeldin M Ibrahim
Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia
Asia Pac J Clin Oncol 6:130-7. 2010
..Because of such features, it is necessary to examine prognostic factors in this population. One such factor is the prognostic role of lymph node ratio (LNR)...
- The present and the future of breast cancer burden in the Kingdom of Saudi Arabia
Ezzeldin M Ibrahim
King Faisal Hospital and Research Center, Jeddah, Saudi Arabia
Med Oncol 25:387-93. 2008
..This work was designed to study female breast cancer as a model to assess future cancer burden and the impact on healthcare resources...
- Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries
Meteb Al-Foheidi
Princess Noorah Oncology Center, King Abdulaziz Medical City, PO Box 9515, Jeddah 21423, Kingdom of Saudi Arabia
Med Oncol 30:471. 2013
..We also provide recommendations concerning rational preventive strategies for breast cancer control for women in DLICs...
- Folic acid supplementation for the prevention of recurrence of colorectal adenomas: metaanalysis of interventional trials
Ezzeldin M Ibrahim
Department of Medicine and Oncology, King Faisal Specialist Hospital and Research Center, PO Box 40047, Jeddah, 21499, Kingdom of Saudi Arabia
Med Oncol 27:915-8. 2010
..Future trials should examine the effect of different dosage and duration. Moreover, the confounding effect of dietary and life style habits should be carefully controlled...
- Past, present and future of colorectal cancer in the kingdom of saudi arabia
Ezzeldin M Ibrahim
Department of Oncology and Hematology, King Faisal Specialist Hospital and Research Centre, Jeddah, Kingdom of Saudi Arabia
Saudi J Gastroenterol 14:178-82. 2008
..Pragmatic recommendations to face that challenge are discussed. The present work could serve as a model to study other prevalent types of cancer, particularly in developing countries...
- Adjuvant chemotherapy in 780 patients with early breast cancer: 10-year data from Saudi Arabia
Ezzeldin M Ibrahim
Department of Oncology, King Faisal Specialist Hospital and Research Center, Jeddah, Kingdom of Saudi Arabia
Med Oncol 22:343-52. 2005
....
